Subcutaneous daratumumab with lenalidomide significantly increased MRD-negative conversion rates compared to lenalidomide ...

Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...

Central Screening enhances trial enrollment by integrating technology and expert oversight, streamlining the process for community oncology practices. The system utilizes Genospace to match patient ...

The trial enrolled patients with unresectable metastatic melanoma who had at least 1 prior line of therapy that had to have the anti–PD-1 therapy backbone. They could or could not have had a BRAF ...

Trastuzumab deruxtecan (T-DXd) significantly improves IDFS over trastuzumab emtansine (T-DM1) in high-risk HER2-positive early breast cancer post-neoadjuvant therapy. The DESTINY-Breast05 trial ...

Early-stage squamous cell carcinoma of the esophagus is primarily treated with endoscopic resection, while esophagectomy or chemoradiotherapy may be considered for select patients based on staging and ...

Shane Dormady, MD, discusses the unique emotional care needs of young adults with cancer, emphasizing hope and holistic support for better outcomes. Cancer care for younger adults emphasizes emotional ...

The FDA approved Guardant 360 CDx for identifying ESR1 mutations in advanced breast cancer patients eligible for imlunestrant ...

Cancer care for younger adults emphasizes emotional well-being and multidisciplinary support, transforming treatment ...

David Chism, MD: For pairing it with the immunotherapy, I would prefer just 1 chemotherapy rather than ...

Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies ...

FDA lifts REMS program for vandetanib, affirming safety in thyroid cancer treatment as healthcare providers ensure effective ...